Crescita Therpeutc J (TSE:CTX)
TSX:CTX
Want to see TSE:CTX full AI Analyst Report?
Total Valuation
Crescita Therpeutc has a market cap or net worth of C$13.96M. The enterprise value is C$5.72M.
Market CapC$13.96M
Enterprise ValueC$5.72M
Share Statistics
Crescita Therpeutc has 18,613,937 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding18,613,937
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Crescita Therpeutc’s return on equity (ROE) is >-0.01 and return on invested capital (ROIC) is -6.41%.
Return on Equity (ROE)>-0.01
Return on Assets (ROA)>-0.01
Return on Invested Capital (ROIC)-6.41%
Return on Capital Employed (ROCE)-0.07
Revenue Per Employee297.44K
Profits Per Employee-1.30K
Employee Count71
Asset Turnover1.04
Inventory Turnover2.28
Valuation Ratios
The current PE Ratio of Crescita Therpeutc is ―. Crescita Therpeutc’s PEG ratio is 1.02.
PE Ratio―
PS Ratio0.43
PB Ratio0.58
Price to Fair Value0.58
Price to FCF12.23
Price to Operating Cash Flow13.01
PEG Ratio1.02
Income Statement
In the last 12 months, Crescita Therpeutc had revenue of 21.12M and earned -92.00K in profits. Earnings per share was >-0.01.
Revenue21.12M
Gross Profit10.37M
Operating Income-1.02M
Pretax Income-83.00K
Net Income-92.00K
EBITDA479.00K
Earnings Per Share (EPS)>-0.01
Cash Flow
In the last 12 months, operating cash flow was 1.07M and capital expenditures 442.00K, giving a free cash flow of 1.51M billion.
Operating Cash Flow1.07M
Free Cash Flow1.51M
Free Cash Flow per Share0.08
Dividends & Yields
Crescita Therpeutc pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.79
52-Week Price Change29.31%
50-Day Moving Average0.61
200-Day Moving Average0.50
Relative Strength Index (RSI)78.98
Average Volume (3m)12.63K
Important Dates
Crescita Therpeutc upcoming earnings date is May 13, 2026, TBA (Confirmed).
Last Earnings DateMar 31, 2026
Next Earnings DateMay 13, 2026
Ex-Dividend Date―
Financial Position
Crescita Therpeutc as a current ratio of 3.33, with Debt / Equity ratio of 2.14%
Current Ratio3.33
Quick Ratio2.33
Debt to Market Cap0.04
Net Debt to EBITDA-17.21
Interest Coverage Ratio-24.33
Taxes
In the past 12 months, Crescita Therpeutc has paid 9.00K in taxes.
Income Tax9.00K
Effective Tax Rate-0.11
Enterprise Valuation
Crescita Therpeutc EV to EBITDA ratio is 1.68, with an EV/FCF ratio of 1.09.
EV to Sales0.04
EV to EBITDA1.68
EV to Free Cash Flow1.09
EV to Operating Cash Flow0.75
Balance Sheet
Crescita Therpeutc has C$8.58M in cash and marketable securities with C$334.00K in debt, giving a net cash position of C$8.24M billion.
Cash & Marketable SecuritiesC$8.58M
Total DebtC$334.00K
Net CashC$8.24M
Net Cash Per ShareC$0.44
Tangible Book Value Per ShareC$0.75
Margins
Gross margin is 54.28%, with operating margin of -4.84%, and net profit margin of -0.44%.
Gross Margin54.28%
Operating Margin-4.84%
Pretax Margin-0.39%
Net Profit Margin-0.44%
EBITDA Margin2.27%
EBIT Margin-4.84%
Analyst Forecast
The average price target for Crescita Therpeutc is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast7.85%
EPS Growth Forecast96.47%